Destination XL Group (DXLG) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
19 Mar, 2026Executive summary
Entered into a merger agreement with FullBeauty Brands in December 2025, expected to close in Q2 2026 pending shareholder approval, targeting $1.2B in revenue and $25M in annual cost synergies.
Fiscal 2025 sales declined 6.9% to $435.0M, with comparable sales down 8.4% year-over-year; both stores and direct channels saw declines.
Net loss for fiscal 2025 was $(35.9)M, or $(0.66) per diluted share, compared to net income of $3.1M in fiscal 2024.
Severe Arctic weather in January 2025 disrupted store operations, but sales trends improved in February and March 2026, with comp sales at -1.3% in February.
Strategic focus remains on cost control, inventory discipline, private brand expansion, digital enhancements, and initiatives like FiTMAP.
Financial highlights
Q4 2025 sales were $112.1M, down from $119.2M in Q4 2024; full-year sales were $435M, down from $467M.
Gross margin for fiscal 2025 was 43.4%, down from 46.5% in 2024, impacted by higher occupancy costs and tariffs.
Adjusted EBITDA for the full year was $1.6M, down from $19.9M in 2024.
Ended the year with $28.8M in cash and investments, no debt, and $55.1M in credit facility availability.
Took a non-cash charge of $20.4M in Q4 to establish a full valuation allowance against deferred tax assets.
Outlook and guidance
No specific financial guidance for fiscal 2026 provided due to pending merger; expect to revisit guidance post-transaction.
Anticipate comp sales improvement in the first half of 2026, aiming for break-even before summer and positive comps later in the year.
Capital expenditures for 2026 expected to be $8–12M, focused on technology and infrastructure, with new store openings paused.
Private brand penetration targeted to exceed 60% in fiscal 2026 and 65% in fiscal 2027.
Latest events from Destination XL Group
- Q2 sales and profit dropped, leading to lower full-year guidance and tighter capital discipline.DXLG
Q2 202522 Jan 2026 - Sales and margins declined, but inventory and liquidity remained strong.DXLG
Q3 202512 Jan 2026 - Sales and earnings fell, but margins and cash flow stayed strong amid sector headwinds.DXLG
Q4 202526 Dec 2025 - Sales declined and a merger with FullBeauty aims for $25M synergies and $1.2B in sales.DXLG
Q3 202612 Dec 2025 - Shareholders will vote on directors, executive pay, auditor ratification, and review ESG progress.DXLG
Proxy Filing1 Dec 2025 - Shareholders will vote on director elections, executive pay, plan amendments, and auditor ratification.DXLG
Proxy Filing1 Dec 2025 - Q1 sales fell 8.6% with a net loss, but tech and store initiatives support future recovery.DXLG
Q1 202625 Nov 2025 - Q2 sales fell 7.5% with net loss, as private brands and tech gain focus amid sector headwinds.DXLG
Q2 202623 Nov 2025